Life Sciences, Biotech, Boards of Directors

Another Biogen Director to Retire

Ryan McBride 8/26/09

Biogen Idec reports today that Cecil Pickett, the biotech firm’s president of R&D, will be leaving his position on the board of directors when he retires on Oct. 5. This is a change from the March 2009 announcement of Pickett’s retirement, when the Cambridge, MA-based firm (NASDAQ:BIIB) said he would stay on the board after retiring from his executive role. Last month the company revealed that Biogen co-founder and Nobel laureate Phil Sharp was retiring from the company’s board.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.